Compare AdaptHealth Corp (AHCO) vs Caesars Entertainment Inc (CZR) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AdaptHealth Corp vs Caesars Entertainment Inc — how do they compare? AdaptHealth Corp trades at $10.08 (market cap $1.38B), while Caesars Entertainment Inc trades at $29.8 (market cap $6.18B). The key difference: Caesars Entertainment Inc is far larger — about 4.5× AdaptHealth Corp's market cap, and Caesars Entertainment Inc is trading nearer its 52-week high, AdaptHealth Corp nearer its low. Which is the better fit depends on your goals.
| AHCO | CZR | |
|---|---|---|
Market Cap | $1.38B | $6.18B |
Sector | Health | Consumer Cyclical |
52-Week High | $13.38 | $31.51 |
52-Week Low | $8.68 | $18.14 |
Enterprise Value | $3.33B | $30.24B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AdaptHealth (AHCO) trades at $10.27, down 4.55% today, with neutral technical signals and mixed fundamental performance. The company reported Q1 2026 earnings miss with negative EPS of -$0.06 versus $0.0125 expected, continuing a pattern of recent quarterly misses. Despite revenue growth to $3.3B projected for 2026, net income remains negative with -2.43% margin. Analyst consensus remains bullish with 75% buy ratings and $14.80 price target, representing 44% upside potential from current levels.
The investment case balances strong analyst support and reasonable valuation (P/S 0.42, EV/EBITDA 7.17) against persistent profitability challenges. Recent refinancing improves financial flexibility, but execution on cost controls and margin improvement remains critical. The stock offers significant upside if management can translate revenue growth into sustainable profitability, though current negative earnings trend presents near-term headwinds.
CZR trades at $30.35, down 0.13% with a neutral technical stance despite bullish moving averages. The company reported a net loss of $502M in 2025 with negative margins, though revenue grew to $11.49B. Valuation ratios like P/E of 10.42 and P/S of 0.54 appear attractive, but recent earnings misses and a pending acquisition by Fertitta Entertainment at $31.00 per share dominate sentiment. Cash flow trends show improving operational performance with net cash flow narrowing to -$32M in 2025.
The outlook is mixed: the acquisition offers a near-term floor, but operational losses and high debt of $12.03B pose risks. Analysts are cautious with 63.3% hold ratings, citing competitive pressures and integration uncertainties. Investors should weigh the buyout premium against fundamental weaknesses in the leisure sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AdaptHealth Corp
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →About Caesars Entertainment Inc
Caesars Entertainment includes around 50 domestic gaming properties across Las Vegas (50% of 2021 EBITDAR before corporate and digital expenses) and regional (63%) markets. Additionally, the company hosts managed properties and digital assets, the later of which produced material EBITDA losses in 2021. Caesars' U.S. presence roughly doubled with the 2020 acquisition by Eldorado, which built its first casino in Reno, Nevada, in 1973 and expanded its presence through prior acquisitions to over 20 properties before merging with legacy Caesars. Caesars' brands include Caesars, Harrah's, Tropicana, Bally's, Isle, and Flamingo. Also, the company owns the U.S. portion of William Hill (it plans to sell the international operation in 2022), a digital sports betting platform.
Read more on CZR →
